He co-founded Heptares (now Sosei Heptares) in 2007, a company that has since produced over 250 GPCR Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Sosei and became Sosei Heptares . Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory

Alastair Brown (Sosei Heptares), where she is currently a final year Ph.D. student.

These successes enabled the US$400M sale of Heptares Therapeutics Ltd. to the Sosei Group Corporation

Therapeutics and served as Chief Scientific Officer for twelve years, through the company's acquisition by Sosei As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery